GB0619816D0 - Novel interferon-alpha constructs for use in the treatment of cancer - Google Patents
Novel interferon-alpha constructs for use in the treatment of cancerInfo
- Publication number
- GB0619816D0 GB0619816D0 GB0619816A GB0619816A GB0619816D0 GB 0619816 D0 GB0619816 D0 GB 0619816D0 GB 0619816 A GB0619816 A GB 0619816A GB 0619816 A GB0619816 A GB 0619816A GB 0619816 D0 GB0619816 D0 GB 0619816D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- cancer
- treatment
- novel interferon
- alpha constructs
- constructs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0619816A GB0619816D0 (en) | 2006-10-06 | 2006-10-06 | Novel interferon-alpha constructs for use in the treatment of cancer |
| PCT/GB2007/003814 WO2008041014A2 (en) | 2006-10-06 | 2007-10-08 | Interferon- alpha constructs for use in the treatment of diseases characterised by abnormal cell proliferation such as cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0619816A GB0619816D0 (en) | 2006-10-06 | 2006-10-06 | Novel interferon-alpha constructs for use in the treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0619816D0 true GB0619816D0 (en) | 2006-11-15 |
Family
ID=37454139
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB0619816A Ceased GB0619816D0 (en) | 2006-10-06 | 2006-10-06 | Novel interferon-alpha constructs for use in the treatment of cancer |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB0619816D0 (en) |
| WO (1) | WO2008041014A2 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
| JP2015513913A (en) * | 2012-04-02 | 2015-05-18 | モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | Modified polynucleotide |
| US10501513B2 (en) | 2012-04-02 | 2019-12-10 | Modernatx, Inc. | Modified polynucleotides for the production of oncology-related proteins and peptides |
| WO2014089354A1 (en) | 2012-12-07 | 2014-06-12 | The Regents Of The University Of California | Cd138-targeted interferon demonstrates potent apoptotic and anti-tumor activities |
| WO2014194100A1 (en) | 2013-05-29 | 2014-12-04 | The Regents Of The University Of California | Anti-cspg4 fusions with interferon for the treatment of malignancy |
| CA3098394A1 (en) * | 2018-06-01 | 2019-12-05 | Alfacyte Limited | Compositions and methods relating to the treatment of diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2825102B1 (en) * | 2001-05-23 | 2003-08-29 | Genodyssee | NOVEL POLYNUCLEOTIDES AND POLYPEPTIDES OF INTERFERON ALPHA 14 |
| US7597884B2 (en) * | 2004-08-09 | 2009-10-06 | Alios Biopharma, Inc. | Hyperglycosylated polypeptide variants and methods of use |
| WO2006111745A2 (en) * | 2005-04-20 | 2006-10-26 | Viragen Incorporated | Composition and method for treating viral infection |
-
2006
- 2006-10-06 GB GB0619816A patent/GB0619816D0/en not_active Ceased
-
2007
- 2007-10-08 WO PCT/GB2007/003814 patent/WO2008041014A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008041014A3 (en) | 2008-07-31 |
| WO2008041014A2 (en) | 2008-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE037109T2 (en) | Endoxifen for use in the treatment of cancer | |
| HRP20160949T1 (en) | Novel compositions and methods for cancer treatment | |
| IL195731A0 (en) | Pyrimidine derivatives useful in the treatment of cancer | |
| SI1978947T1 (en) | Nitrooxyderivatives for use in the treatment of muscular dystrophies | |
| HK1136822A1 (en) | Therapeutic compounds and their use in cancer | |
| HK1215683A1 (en) | Antifolate agent combinations in the treatment of cancer | |
| LT2450041T (en) | Improved testosterone gel for use in the treatment of hypogonadism | |
| EP2049139A4 (en) | Treatment of ras-expressing tumors | |
| EP2049151A4 (en) | Methods and compositions for the treatment of cancer | |
| HK1256479A1 (en) | Grn163l for use as telomerase inhibitor in the treatment of cancer | |
| AU2006251167A8 (en) | Tetrahydropyridothiophenes for use in the treatment of cancer | |
| AU2006251169A8 (en) | Tetrahydropyridothiophenes for use in the treatment of cancer | |
| HK1100484A1 (en) | Application of n-butylidenephthalide in preparing cancer treatment medication | |
| PL2012805T3 (en) | Therapeutic composition and use | |
| GB0619816D0 (en) | Novel interferon-alpha constructs for use in the treatment of cancer | |
| HK1151971A1 (en) | Compounds for use in the treatment of cancer | |
| ZA201108106B (en) | Use of phthalimide derivatives in the treatment of diseases | |
| EP1904088A4 (en) | Compositions and methods for the treatment of cancer | |
| ZA200810524B (en) | Pyrimidine derivatives useful in the treatment of cancer | |
| GB0505203D0 (en) | Skin composition treatment | |
| IL198070A (en) | Sirna for use in the treatment of ischemia-reperfusion injury | |
| GB0722338D0 (en) | Novel use and treatment | |
| GB0622040D0 (en) | Skin treatment composition | |
| HK1125634A1 (en) | Pharmaceutical for use in the treatment of ureterolithiasis | |
| GB0604114D0 (en) | Combinations for the treatment of cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |